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1. Contradictions of New Family Life Cycle(s) 
in Hypermodernity? 
Not until recent decades of hyper-modernization 
with a corresponding drop of total fertility rate (of 
less than 2 per woman-life course) with less new born 
babies, human reproduction historically has been a 
natural cause and process for people survival and 
succession. But “infertility” has been both a private 
problem of husband and (particularly for) wife 
and a social issue; and it is as if a taboo somewhat 
unspoken to cause embarrassment for the concerned.   
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Reproductive power is the basic drive for any living species’ survival. Human beings have been 
successfully to reproducing themselves to capture the world and enjoying a commanding posi-
tion in natural world… With urbanizing and hyper-modernizing forces, demographic transi-
tions move towards ageing societies globally – the drop of human fertilities (total fertility rate 
per woman in her life course) represents an alarming quest for the longevity and survival of 
human species (homo sapiens) in 21st century and beyond!  
This paper explores human reproduction processes, particularly those are gifted by modern re-
productive medicine and the related technologies; highlighting the contradictions (within three 
inter-related spheres) of dynamic socio-economic forces, developing along the past, present 
and future historical timeline within a wider opportunities structure available in 20th-to-21st 
century. By contrasting social virtues of pre-modern traditionalism (Confucian virtues, say, fi l-
ial piety) and hyper-modern reproductive medicine based promise for better reproductive out-
comes (the better newly born), it articulates that, bioethics for human reproductive medicine, 
is struggling to catch up with both governmental regulatory initiatives and the market-force 
driven higher pricing for the best possible reproductive outcomes – this is evidently shown in 
our study on hyper-modernizing Chinese societies. 
Yet, we are in the new age of technological revolutions, shaping modus operandi of our daily 
life! But our case study on reproductive medicine in ageing Chinese societies discovers that the 
bioethics of reproductive medicine is seemingly so elusive in the public discourse but is admin-
istratively straitjacketed-bound within the governmental and bio-medical professional matrixes 
of rule-proceduralism. Hence, reproductive medicine and its ramifi cations are far from serving 
to revitalize the old social virtues for reproduction of fi lial piety, nor contributing signifi cantly 
for the quality of life in hyper-modernizing society: isn’t something missing-out from the 
(r)evolutionary of bio-medical science advancement?
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Highlighting the contradictions (within three 
inter-related spheres) of dynamic socio-economic 
forces, developing along the past history, present 
development and future prospects in a widening and 
new societal-technology opportunities structure, this 
short brief attempts to examine the highly “intrusive” 
reproductive technology (into male-and-female 
bodies and mind, family and kinship processes alike): 
To what extent new bio-reproductive technology “to 
couple” with socio-cultural structure, and in what 
ways normative -cum- ethical considerations and 
repercussions develop along the new technology life 
course, and the most important is: whose reproductive 
production and bio-technology for whom?
1.1 Dualistic Dynamics in Chinese (Western 
Technology-driven) Hypermodernization?
Against all the odds of infertility, the 1978’s 
biomedical breakthrough for test-tube baby and 
subsequent reproductive technology advancement 
provide hope for the infertile couples; redrawing 
the boundaries and contours of the natural, vis-à-
vis, the artificial, as well as redefining individual 
and family life and humanity at large. The bio-social 
transformation thanks to new biomedical science has 
been complex yet highly differential with the society-
technology nexus in variety of cultural-localities.
For Chinese societies in Asia, most of them have 
been undergoing hyper-modernization in the last 
few decades (1970- onwards) with mostly Western 
technologies adoption, biomedical and reproductive 
technology is among those learning from the 
developed West. In the process of interfacing, or 
interaction, between Western technologies and Asia’s 
socio-cultural idiosyncrasies, there are many forms 
of synergetic and contradictory development….And 
it would be interesting to examine these interfacing 
issues. 
Since the test-tube baby born in 1978, biomedicine 
has started treating infertility as a curable disease 
with assisted reproductive technology (ART) in the 
West. Unlike their Western counterparts, families in 
East Asia’s newly industrializing economies (NIEs) 
under traditional Confucianism inf luences, like 
South Korea, Taiwan, Hong Kong and Singapore(n 
Chinese), the inability to conceive a child is still 
considered not just individual but family-kinship 
(succession) issue. And the emerging regulatory 
f rameworks embracing new biomedicine l ike 
those Ethics Committee or Council on Human 
Reproduction Technology (CHRT, in Hong Kong) are 
more or less being Western “medicalized” (controlled 
by biomedical professions with their policy discourse 
and narratives) in public domain (cf. Lai 2012; 
Madge 2011) .
Among other socio-economic considerations, 
traditional social vir tues of Confucianism are 
still influential in shaping each family member’s 
worldview to reproduce, to fulfill intergeneration 
duties for one’s familial succession (from father-
to-son), along the patriarchy line – the basic for 
fi lial piety (孝) is to reproduce…“不孝有三、無後
為大” (not having son is the worst of the three acts 
against filial piety). In other words, “to-reproduce” 
is the basic for fi lial piety duty (of inter-generational, 
family-kinship contract). 
Given the legal provision, the commonly practice 
of ART, in vitro fertilization (IVF), a process by 
which an egg is fertilized by sperm (out), empowers 
the concerned bodies to have many trials (and errors) 
for achieving human reproduction purpose – which 
opens the spaces (egg+sperm+embryo) for the re-
creation of new life. This has been reinforcing new 
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innovations for human reproduction in recent years 
with biomedical engineering targeting women 
as modus operandi (cf. Sharp 2012). Obviously, 
biomedical ART enables a better chance for Chinese 
families to sustain their succession – and the 
technology becomes not just a boost for Chinese 
traditionalism for reproduction; but also a biomedical 
link to bridge the thousand-year old tradition with 
new ART humanity! 
To recapitulate, the Chineseness (of traditionalism) 
for filial piety is undoubtedly a good partner for 
modern bio-reproductive technology as far as 
the functionality and instrumentality of new bio-
science offerings, enable an acceptable though not 
ideal,  solution for family reproductive succession 
along the patriarchy social contours. In short, 
human reproduction (through various ways to create 
offspring) in Chinese societies has more than the 
instrumentality to realize socio-cultural virtues of 
filial piety and patriarch family succession, while 
reinforcing intergeneration contracts for family and 
kinship. 
1.2 Whose New Body from Reproductive 
Technology: Temporal-Spatial Contingency
Giving birth to new life with ART is embedding 
the formation of both “intra-corporeality” (within 
one’s body-corpus) and “inter-corporeality” (between 
bodies-corpus), more even so for the new (alternative) 
genesis of life form, twining more complex nexus 
with natural evolution and artifi cial enhancing.
For those (like women, men or their surrogacy 
mothers) at the receiving ends of ART, they are 
always under stressful conditions, before, at and after 
the reproductive procedure; so do the relationships 
among various agencies involved: say the least is the 
emotional tensions, the ups-and-downs of psycho-
somatic stress before-and-during pregnancy and 
actual labouring….  
Beyond personal and familial nexus of emotional 
attachment; it is the couple’s dynamics and their 
unique family history, vis-à-vis, the “business as 
usual” for ART professionals, which shape not just 
the complex process of novice human reproduction, 
but also redefines the essence of humanity as (to 
be) experienced by the (passive) recipients of new 
biomedical treatment-solution. There are three 
contesting arenas could be delineated in this brief, 
following the relationship of ART with the inter-
corporeality and temporality, agencies for (against) 
biomedicine, and the related externalities.
 To examine the dynamics of new life making 
thanks to ART, this paper examines three inter-
related spheres, mirror-imaging the Beauchamp 
(2003; Beauchamp & Childress (2008)’s three levels 
of biomedical ethics for understanding the related 
structure and dynamics, with specifi c reference to two 
distinctive yet inter-related mechanisms for coping 
with the “genesis” or “creation” of human beings; 
namely, the interactions between/among biomedical 
technology gate-keepers and their clientele, within 
the temporal (timing, when and how long?) and 
spatial (where reproductive technology and its 
derivatives take place: from microscopic egg plus 
sperm to transnational surrogacy) domains, along the 
timelines of new life genesis in a globalizing, hyper-
modernizing, world of socio-cultural transformation.  
Obviously, in our framework, there is a strong 
sense for new emerging opportunities structure 
thanks to  differential modernization trajectories on 
the one hand; and the rise of the varieties of second 
modernity (Beck & Grande 2010), on the other. For 
Asia’s modernization drama, Hong Kong exemplifi es 
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2. Differential Reproductive Technology 
Nexus: Proceduralism over Humanity
Regulatory system to monitor and guiding ART 
is a new policy evolution, juxtaposing scientific 
advancement of hyper-modernization. Hong Kong 
is no exception to this catching-up for regulatory 
framework for new scientific application for (old) 
human (egg plus sperm) bodies and new babies. 
2.1 Functionality of Biomedicine for Chinese 
(Individual) Wishes: The Law to Serve?
The legal foundation for regulating ART practices 
in Hong Kong is Human Reproductive Technology 
Ordinance (Hong Kong Law: Cap.561, 2001, 
2007): it regulates ART procedures, and the use, 
for research and other purposes, of embryos and 
gametes; to confi ne the provision of ART procedures 
to infertile couples subject to any express provision 
to the contrary in any code; to regulate surrogacy 
arrangements; to establish a Council on Human 
Reproductive Technology (CHRT). Accordingly, the 
Council on Human Reproductive Technology (人 類
生殖科技管理局) shall-
(a)keep under review information about-
(i) embryos and any subsequent development 
of embryos;
(ii)relevant activities;
(iii) surrogacy arrangements, and advise the 
Secretary for Food and Health, if the 
Secretary asks it to do so, about those 
matters; (Amended L.N. 106 of 2002; 
L.N. 130 of 2007)
such – the very obvious paralleling (or partial) 
Westernization of Japan, China and South Korea 
demonstrates the thousand-year old socio-cultural 
structure and dynamics embedded in in hyper-
economic growth of the (Western?) modernization 
trajectories (Han & Shim 2010; Suzuki, et.al. 2010; 
Yan 2010; Chang & Song 2010). More specific for 
indicative illustration is shown here (Fig.1):
Figure 1: Dynamics of Reproductive Technology (RT) in (Asia) Hyper-Modernization Trajectories 
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(b)publish or otherwise make available-
(i) l ists of premises at which relevant 
activities may be carried on pursuant to a 
licence;
(ii) statistics and summaries concerning 
relevant activities which have been 
carried on;
(c) provide,  to such extent as it  considers 
appropriate, information for persons (including 
persons proposing to be persons)-
(i)to whom licences apply;
(ii) to whom a reproductive technology 
procedure is provided; or
(iii) providing gametes or embryos for use 
for the purposes of a relevant activity or 
surrogacy arrangement;
(d) promote (by the dissemination of information 
and in other ways) informed public debate on 
the medical, social, moral, ethical and legal 
issues that arise from relevant activities and 
surrogacy arrangements;
(e) liaise and co-operate with any person in any 
place outside Hong Kong-
(i) performing in that place any functions 
which, in the opinion of the Council, are 
similar (whether in whole or in part) to 
any of the Council’s functions under this 
Ordinance; and
(ii) in respect of any matters of mutual 
interest concerning relevant activities and 
surrogacy arrangements, in particular 
any ethical or social issues ar ising 
therefrom; and
(f) perform such other functions as are imposed 
on it under this Ordinance or any other 
enactment.
Hong Kong’s regulatory body for ART is the 
CHRT (http://www.chrt.org.hk/), it is a relatively new 
one, among biomedical regulatory bodies like the 
Hong Kong Medical Council (HKMC). And CHRT 
is a statutory body established under section 4 of the 
Human Reproductive Technology Ordinance (Cap. 
561) (“The Ordinance”) in April 2001 to regulate 
the provision of ART procedure; the conducting of 
embryo research; the handling, storing or disposing 
of gametes or embryos used or intended to be used in 
connection with ART procedure or embryo research 
and surrogacy arrangement.  functions as central 
administrative body for issues and clinical procedure 
related to biomedical “intervention” for reproductive 
health (Ng, et al.2003). In spite of the Westernized 
biomedical advancement of Hong Kong, its regulatory 
framework is still novice, compared with the Human 
Fertilisation and Embryology Authority (HFEA) of 
the United Kingdom (http://www.hfea.gov.uk/index.
html).
2.2 Regulating ART in Hong Kong: Maximal 
Biotech - Minimal Ethics?
Since Hong Kong government’s enactment of 
Human Reproductive Technology Ordinance (Cap. 
561) in 2000 (and revised in 2007), total number of 
babies born with assisted reproductive technology 
were only a few dozen before 2010, according to 
CHRT statistics (CHRT 2009, 2010): for instance, 
there were only 19 new born in 2009, and at most 
31 (who were ongoing pregnancy as recorded in 
December 2010) for 2010-2011.In short, the Hong 
Kong case shows, and as expected, that ART was 
highly developed but under-utilized by infertile 
couples at the early phase (2007-2010).   
According to 2010 statistics, none case for an 
earlier assisted reproductive technique (accepted by 
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Roman Catholic Church) of GIFT (Gamete Intra-
Fallopian Transfer) which fertilization of egg occurs 
inside the woman’s body (not outside) was recorded 
in Hong Kong. Nor was the case for the more 
intrusive procedure (for women) of ZIFT-PROST 
when no procedure was performed. More specific, 
this refl ects the obvious trade-off between risk-and-
outcome, as well as old and new procedure for ART 
human reproduction (Fig.2 and Fig.3).
But there was an increasing trend for more couple 
to take up the infertility treatment with ART: for 
the year ending 2010, total number of users for 
ART increased to 8668 (patients) – still a relatively 
low level given the good availability of advanced 
reproductive technology centres in Hong Kong. More 
specifi c, majority of (female) users for ART were in 
their mid-30s cohort. 
Figure 2: Type of RT Procedure in Hong Kong, 2010.
Figure 3: Live Birth Rates among Women by Different Age Group by RT Procedure
( Sourc: CHRT, 2012 )
(Source: CHRT, 2012)
20
Journal  of  Policy  Studies   No.43  (March  2013)
In addition to age and biological chronology of 
women, ART seemingly is also a form of “stratifi ed” 
human reproduction in Hong Kong, following other 
developed economies’ experience. The package-
price for reproduction at public hospital is nearly 
the average household (of four members) median 
income of HK$19,000 in Hong Kong and the private 
providers charge about triple or more that amount. 
Hence, only those affordable can opt for such new 
technological blessing. 
Beyond the reproductive cost for pre-natal care for 
babies, nurturing (monetary, social and temporal) 
cost for children in Hong Kong is exponentially high 
that the former British colony has the lowest total 
fertility rate of 1 (per woman life course) in Asia 
since 2000.  
In November 2012, there were 36 (with 6 in public 
hospital) licensed centres for Artifi cial Insemination 
by Husband, 12 (with 3 in public hospital) licensed 
ART Treatment Centres and 2 ART Research Centres 
by the universities. Hence, the standards of ART are 
matching the developed nations. And the outcome of 
RT is comparable with international standards though 
there is differential in terms of ongoing pregnancy 
rate with different technology procedures. The 
overall average (despite its misleading indication) is 
within the 20%-30% international norms: in 2010: 
26.3% for IVF and 25% for ICSI with IVF; somewhat 
similar to 2009 fi gures of 28.8% for IVF and 24.8% 
for ICSI with IVF (CHRT 2010).
Overall, the service needs are not significant if 
compared with total health services in Hong Kong. 
And because of this minimal utilization and demand, 
not much attention has been placed on ART and its 
bioethics, as compared with the end-of-life medical 
procedure everyone has to face….
2.3 The Perplexity of Reproductive Technology-
driven Proceduralism
Juxtaposing the advancement of biomedical 
reproductive technology in the period 1970s to 2000s, 
the t ransformat ion of law gover n ing fami ly 
relationship and reproduction in Hong Kong has 
been dramatic, if not unprecedented, reflecting the 
rate of hyper-modernization: Hong Kong law banned 
polygamy in 1971, fi rst test-tube baby born in Great 
Britain in 1978 and the 2000 Hong Kong legislation 
on Human Reproductive Technology Ordinance 
(Cap.561) enacted. This has posed substantial burden 
for Hong Kong society to cope with dramatic changes 
in the Chineseness and Western technology, as well 
as the socio-legal governance of human reproduction 
and family relat ionships – th is is the par t ia l 
bilingual perplexity of (legal) governance of human 
reproductive technology in Hong Kong society.
Furthermore, the perplexity of ART procedure 
in Hong Kong is complicated not just by different 
conceptions of (new, born or unborn) life, but also the 
partial bilingualism of Chinese (in daily use: spoken 
Cantonese and written Mandarin) and (the official 
legal and biomedical) English – an integral part of 
Western modernization with British colonial legacies.
Motherhood (and parenthood) in Hong Kong’s 
Human Reproduct ive Technology Ordinance 
(Cap. 561), though bilingual in legislation and 
for enforcement, the definition(s) of motherhood 
(parenthood) for the sourcing of egg (and sperm 
from the father) though reproductive technologically 
well defined but it is contestable in socio-cultural 
perspective, if and follow Chinese traditionalism of 
polygamy (banned in Hong Kong just a few decades 
ago, since 1971)…. 
For instance, related to (dualistic meanings of) the 
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interpretation, the Ordinance (Cap.561) states that
“surrogacy arrangement” (代 母 安 排 ) means 
an arrangement by virtue of which a woman to 
whom it relates would be a surrogate mother 
were she to carry a child pursuant to the 
arrangement;
“surrogate mother” (代母) means a woman who 
carries a child-
(a)pursuant to an arrangement
(i) made before she began to carry the 
child; and
(ii) made with a view to any child carried 
pursuant to the arrangement being 
handed over to, and the parental rights 
being exercised (so far as practicable) 
by, another person or persons; and
(b) conceived by a reproductive technology 
procedure.
Similarly, for the interpretation on “in vitro 
fertilization” (體外受精)-
(a) means the fertilization of an egg by sperm 
outside the human body, whether or not the 
egg was originally removed from the body of 
that or any other woman;
(b) inc ludes  any procedure involving the 
induction or aspiration of an egg, or the 
culture of an egg for the purposes of any such 
fertilization;
Due to its highly legalistic and reproductive 
technical (yet narrowly defined) interpretation, 
not least the possible bilingual differential (mis-)
interpretations, it is quite diffi cult for general public 
to make sense to  use possible arrangement for ART 
without experts’ support. 
2.4 The Bounded Regulatory Governance for 
Biomedical Errors
Since its establishment, there are some problems 
for ART procedure in Hong Kong. The Council 
on Human Reproductive Technology (CHRT) has 
addressed these complaints timely but it has never 
taken the utmost stringent (disciplinary) actions. 
Below are two obvious cases. 
 The CHRT secretariat on 11.July 2011 received an 
incident report (for a wrong ART procedure occurred 
on 8.July 2011) from one ART Centre (licensed under 
Cap. 561), concerning the wrong transfer of embryos 
in the Centre on 8.July 2011. Two embryos belonging 
to a woman were transferred to a wrong woman 
due to failure of a junior embryologist to check the 
labeling of the embryos.  According to the Centre, 
the error was immediately found and the Centre 
took remedial actions including retrieval of the two 
transferred embryos. Both women were informed of 
the incident and counseled.
For this wrong procedure or failure, the CHRT 
issued a press statement (issued 17:22 Hong Kong 
Time; 16.July 2011), after a prompt one-week 
investigation and its Investigation Committee (the 
Committee) of the (CHRT) at its meeting on 15.July 
2011 evening, and decided not to suspend the licence 
of Victory ART Laboratory Limited (the Centre) as 
a treatment centre for carrying out ART procedure 
with storage of gametes and embryos as the CHRT 
was satisfied with the Centre’s remedial measures 
for the accident (see http://www.info.gov.hk/gia/
general/201107/16/P201107160194.htm).
Ac cord i ng  to  t he  C H RT’s  r ep or t :  i t  wa s 
unnecessary to suspend the Centre’s licence in 
accordance with section 29 of Cap. 561 as the 
error involved was human rather than systematic. 
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Moreover, the Centre has demonstrated to the 
satisfaction of the Committee that the problem in the 
checking procedure has been rectifi ed by introducing 
a double checking mechanism by two experts on each 
and every step involved. 
Obviously, the above case demonstrates the failure 
not just in systematic terms; but against a very basic 
common sense that due to the lacking of a double-
check procedure in place, errors have occurred; 
and a new system of double-checking procedure 
therefore will be in place after the incident: Isn’t it a 
system failure or just human error? In other words, 
it is highly questionable whether human error (of 
no double-checking procedure on each and every 
step involved) was attributed to a systematic failure 
(in response, a double-check system was later 
introduced). To uphold the most stringent criteria (and 
subsequent sanction) for ART procedure (failure), a 
more pro-active and responsive action should have 
been taken by CHRT.  
Furthermore, the limited regulatory (sanctioning) 
function, partly structural weakness, of CHRT 
is demonst rat ively shown in cross-border or 
transnational reproductive technology (trading) 
for egg-and-sperm. On the issue of childbirth by 
surrogacy arrangements, surrogacy arrangements on 
a commercial base is prohibited in Hong Kong, but 
the regulatory authority has no action taken to uphold 
the law (Cap.561). It is more or less challenged by 
wealthy privileged people, or anyone exit from Hong 
Kong system of ART. Demonstratively by Mr. LEE 
Shau-kee, the 82-year-old chairman of property 
developer, Henderson Land Development Ltd., 
and one of the richest men in Asia, and his eldest 
unmarried son.  On 26.October 2010, Henderson 
Land Development Ltd. announced that triplets 
(three male babies, by coincidence or by reproductive 
design in October?) born via surrogate to bachelor 
Peter LEE Ka-Kit, then age 47,  heir to his aged (82) 
father’s business empire in Asia. Since then, it has 
sparked international controversial discussion of 
surrogacy laws and regulatory measures on ART. 
Apparently through a surrogate hired in USA, such 
financial transactions for commercial surrogacy are 
illegal (given the reproductive law Cap.561) in Hong 
Kong, even if they take place elsewhere. 
Due to not enough evidence to show that a 
criminal offence had been committed, the Hong 
Kong authority has closed the fi le on after 10-month 
investigation into an alleged surrogacy deal involving 
Henderson Land Development vice-chairman Peter 
LEE Ka-kit who had three sons born to him via 
surrogacy (SCMPost, 16.October 2011; The Wall 
Street Journal 14.December 2011). 
Nor the Hong Kong authority (CHRT) for Cap.561 
has not pursuit any legal action against such illegal 
act. CHRT and HKMC just issued a joint statement 
to re-assert the illegality for commercial surrogacy 
in September 2011 (http://www.chrt.org.hk/english/
publications/fi les/joint_statement_fair.pdf) that:
Surrogacy arrangements on a commercial basis 
are prohibited under the Ordinance (Cap.561)…. 
It is unlawful to use in a surrogacy arrangement 
the gametes of persons other than the husband 
and wife in a marriage to whom the child carried 
will be handed over…. Besides legal sanctions 
for contravention of the provisions of the 
Ordinance, a medical practitioner may also be 
guilty of professional misconduct and liable to be 
disciplined by Medical Council of Hong Kong. …
In short, the CHRT failed to reply to inquiries 
about whether they would be following up on 
the case. No full scale investigation leading to 
prosecution has been made under the Human 
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Reproductive Technology Ordinance (Cap.561) since 
it was passed in 2000! 
3. Multiple Humanity beyond One’s Egg (and 
Sperm) in ART?
Historically (and still the case today) that ART has 
been mostly private wealth-funded. It is developed 
to fit with individual’s solution for infertility, with 
differential consequence for people. For this complex 
processing, the following delineates three levels of 
intrusion of ART into people’s life.  
3.1 1    New Biomedicine for Life: Wealth-
enhanced Choice for Egg+Sperm
ART is fundamentally an integral part of new 
humanity-in-formation, at the micro (1st) level 
for the self-chosen human agencies (mostly of 
women and biomedical professionals). It is more 
psychosocial than biomedical impacts, as new 
biomedical science redefine whose (consented 
partners of egg and sperm), where (whose or which 
body), how (techniques of IVF), when (timing) 
and what (gender-choice) body will be reproduced 
and created, within the given (or the missing) 
regulatory mechanism for human reproduction. More 
importantly, it is the transcending matrix at micro 
(individual) level, messo (familial and biomedicine 
community) and macro (socio-legal) domains. Not 
least, it is about women bodies and their centrality of 
their bio-psychosocial embedded-coupling with new 
biomedical science and the externalities. Here “the 
physicality or materiality of the relationships between 
people who give organs and tissues (donate eggs 
and sperm alike) and those who receive them, and 
the imaginary of this connection, must be taken into 
account along with the social values attached to those 
relationships. It is the constellation of relationships in 
which women’s bodies and their own body parts (e.g. 
eggs) are materially exchanged and acquire particular 
meanings” in / through new biomedicine in practice 
(O’Riordan & Haran 2009: 192-193).
For reproductive biomedicine, the gender bias 
is more than obvious - or perhaps, a privileged 
biological advantage for women!  In addition to the 
self-chosen preference to engage for biomedical 
solution-seeking, in most ART procedures, the 
presentation of women as the body to carry eggs 
(“exported”) and bearing embryo (to another woman 
in surrogacy case) is not just gender biased, but also 
women are existing “as atomized units”, free from 
a social world who will operate in relation only to 
biomedical advise (likely a solution-focused one for 
biomedical undertaking) in clinical setting  (in which 
they are often already undergoing risky and stressful 
procedure), seems at best disingenuous (O’Riordan & 
Haran 2009: 197).
For last several decades, biomedical (new) science 
miracle advances for new life, beneficiaries for the 
selected or self-chosen few. The intrusive reproductive 
technology has been more for individual bodies’ 
enhancement at private realm than public health or 
social wellbeing – all the concerned agencies are 
focusing on micro-benefits. As biomedical ART is 
more or less solution (or outcome of having babies) 
focused; the psychosocial and spiritual aspects of 
people (women in particular) have been mostly 
neglected – though some bioethical precautionary 
guidelines and procedures par excellence (?) are 
belated mooted and cosmetically put in place in terms 
of legal and biomedical terms.   
st
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3.2 2    Perplexity of Regulatory Framework: 
Governance of What-Whose Life?
Familial support, or its rejection, to opt for 
reproductive biomedicine methods to ensure the 
continuity of family lines of succession, reemphasizes 
the impor tance of not just bio-psychological 
intervention for the concerning couple (and their 
surrogacy), but also the functioning of marital-
familial and kinship network within a larger socio-
cultural milieu.
Reproductive biomedicine, operating for private 
sphere but in public domain, is a challenge for any 
regulatory framework to deal with the spectrum 
ranging from egg+sperm, privacy, professional 
competence and privileges, to social values and 
norms with bioethics. 
But most regulatory frameworks for emerging 
sciences, biomedical reproductive technology in 
particular, are administrative-bureaucratization, 
embedding the proceduralization of “business 
as usual”, of bioethics. For example, the Human 
Reproductive Technology Ordinance (Cap.561) and 
it CHRT are mostly dealing with detailed procedure, 
protocol and guideline and the administration of 
them, in and through which it states:  
“reproductive technology procedure” (生 殖 科
技程序) means a medical, surgical, obstetric or 
other procedure (whether or not it is provided to 
the public or a section of the public) assisting or 
otherwise bringing about human reproduction by 
artifi cial means, and includes-
(a) in vitro fertilization;
(b) artifi cial insemination;
(c) the obtaining of gametes;
(d) manipulation of embryos or gametes outside 
the body;
(e) a procedure specif ied in a notice under 
subsection (2)(a)(ii) to be a reproductive 
technology procedure; and
(f) a gender selection achieved or intended to be 
achieved by means of a procedure which falls 
within this defi nition, but excludes a procedure 
specifi ed in a notice under subsection (2)(b)(ii) 
not to be a reproductive technology procedure;
To  r e cap i t u la t e  t he  gover na nce  on  A RT, 
administrative-logics are throughout the processing 
of, and biomedical professionals’ domination over, 
human reproduction and its missing of interfaces with 
society at large – the modus operandi of CHRT with 
some selected representation of interest groups is well 
controlling the regulatory (specific proceduralsm!) 
body. Ethics and norms for good governance on 
human reproduction are subject to bio-scientific 
hegemony. 
The risks of new biomedicine are also under-
articulated in secular narratives, given certain 
advantageous, positively acclaimed, narratives and 
rhetoric by the interest groups for new biomedicine – 
this is clearly shown in the functional representation 
of statutory regulatory bodies on ART which medical 
and research professions dominate most of public 
discourse on the benefi ciaries of new technologies for 
people at large (O’Riordan &  Haran 2009). 
Perhaps because of this system’s self-referentiality 
(pre-empt ing the bioethics) for championing 
biomedical reproductive technology by the state 
and biomedical agencies, people (especially those 
are more wealthy) attempt to “exit” from the system 
to pursuit their own reproductive wishes with 
transnational reproductive tourism.  
nd
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3.3  3    Societal-Technological Historicity: Aged 
Virtues in Transformative Biomedicine?
There are multiple yet inter-related ways to 
conduct ART, the widely use procedure of the In 
Vitro Fertilization Pre-Embryo Transfer (IVF-ET), 
designed to enhance the likelihood of conception in 
couples for whom other fertility therapies have been 
unsuccessful, first successfully used in humans in 
1978. Over the years, the possibility of a continuing 
pregnancy being achieved by IVF has improved from 
practically zero to 25% at IVF clinics worldwide – 
Hong Kong’s biomedical ART achieves such level 
recently as well (CHRT 2010). But the possibility 
of a pregnancy being achieved for any one patient 
cannot be predicted, as it depends on many variables 
- such as age and the reproductive health of both the 
wife and the husband. Moreover, it is high risk too as 
the complex process involves multiple steps resulting 
in the insemination and fertilization of oocytes 
(eggs) in the laboratory. The embryos created in this 
process are then placed into the uterus for potential 
implantation (http://www.ivf.com/overview.html)... 
But most of ART procedures are “autopoietic” 
(self-referential) as biomedical endeavors go in a 
technology creeping modus operandi (O’Riordan & 
Haran 2009: 201) that  
a process by which new technologies create 
affordances for each other and contribute towards 
cultural acclimatization for more technologies; in 
this case the creep is between IVF and cloning. 
The novelty of cloning as a new (reproductive) 
technology retrospectively normalizes the 
existing practices of IVF. These developments 
and the core–creep relationship can be traced 
from IVF practices in the 1970s (Crowe, 1990; 
Pfeffer and Woolet, 1983; Spallone, 1987) 
through to the practices of therapeutic cloning in 
the early 21st century (Haran et al., 2008). 
As proclaimed by most regulatory frameworks over 
reproductive medicine in developed world, egg and 
sperm donor(s) and their corresponding recipient(s) 
should be well informed about the risks and benefi ts 
with subsequent consent for the clinical ART 
procedures; but contextual realities are more or less 
that donors and recipients are self-chosen, for better 
or worse over different motivations, that they are 
bound to be involved in the clinical procedures: as 
their involvement is refl ecting somewhat heightened 
attention, hope and excitement, if not euphoria, for 
futuristic promises of new biomedical offerings under 
the pro-active state policy  development for future 
sciences. 
Recent research also shows that reproductive 
service is demonstratively in favor of the wealth and 
privileged groups and there is continued existence of 
“stratified reproduction” in USA, with evidence of 
group differences in reproductive control and access 
to reproductive health care: women of color were 
overrepresented among people with infertility but 
were underrepresented among those who received 
medical services (Arthur, et al. 2011). This is in line 
with our examination that ART is a socio-economic 
biased one, favoring the privilege ones: the same 
trend is more than obvious for the (price mechanism- 
driven) commodified practice of reproductive 
biomedicine in most developed and emerging 
economies.    
Reproductive technology consists of complex 
-cum- sophisticated procedure, taking and placing 
eggs and sperms for laboratory and woman womb 
aiming for continuing pregnancy. The time for 
considering, deciding and involving in assisted human 
reproduction is a long and enduring one, lasting 
rd
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in terms of months, if not years if the trails do not 
succeed. And egg-and-sperm donors and recipients 
have to undergo biophysical and psychosocial 
stresses, though mostly bear by the female partner(s) 
in human reproduction. 
Yet most of the efforts for reproductive regulatory 
framework development are muddling with legal 
and biomedical professional specificities for self-
referentiality, in terms of guideline, protocol and 
procedural specifi cation of who and for whom, when 
and where, as well as how reproductive technology 
should be taken place, without much considerations 
for human (non-professional) agencies and the rights 
(to opt out) – hence it is not unreasonable to quest 
for: whose body (and for whom calling) for human 
reproduction?
4. Paradoxes of Bio-Medicalization: Multiple 
Humanity (Family) in New Millennium? 
Futuristic biomedical science in 21st Century 
hypermodernity facilitates not just new technologies 
but likely to transform humanity with rejuvenations 
of multiple humanity, new family-kinship relations 
and social relations with emerging novice technology-
driven societal encounters, like new virtual realities 
and the back-to-the-future human relationship when 
traditional family-kinship can be historically or 
chronologically reversible: any life can be possibly 
re-created by biomedical re-engineering…. For the 
likely scenarios, the ending paragraphs of this brief 
make critical remarks.   
4.1 Egg + Sperm Escape from the Womb: 
Champion for New Life (Course)!
New “ i nt r usive”  b iomed ic ine  for  people , 
empowering women in particular, to choose new 
lifestyle(s) and extending their opportunities to make 
up the lost of (reversing or rejuvenating biological) 
critical time (for having baby) set by bio-historic 
limits. For instance, people can now re-create human 
new life at anywhere - anytime (back to the future?) 
as they wishes, given they have stored up their own (or 
other) egg+sperm with ART system. But this is only 
for those privileged ones.
At the society level, there is new opportunities 
structure supported by both wealthy groups and 
biomedica l  sc ience advancement for  human 
reproduction – demonstratively an extension of 
people alternative choice(s) to make for planning 
one’s future (and legacy) and familial succession. 
This is in line with hyper-modernizing systematic 
calling for individual(ism-driven self-) planning 
future in l iberal, global advanced capital ism, 
affecting not just the young and fertile one, but also 
the rich aged one who can still be reproductive active 
as ageing (say, reactivating their previously stored 
eggs and sperms). Hence, a new choice-based auto-
biography in “New Biomedicine Age” is more than 
obvious. The choice biography concept implies not 
just young people, but also the aging ones, to (re-)
plan for their own (not historically defined, aged-
limited and standardized life course). All these 
exercises are not just cognitive-mental one, but are 
being institutionalized into everyday life that people 
are engaged in the projection, planning and evaluation 
of their own life course with new Weltanschauung 
(worldview) – the biographization of one’s own life 
course (Vinken 2004; Macmillan, Ed. 2005).
Helping the self-biographization of life course of 
younger generation are the state policy, new sciences 
and new family wealth and outlook in late 20th 
Century. Both the state and the upwardly mobile, 
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better-off family (in comparison with their previous 
cohort) dynamics reinforce the delaying and exit-
(and-re-engaging) strategies of the younger (and the 
aged) generation to take up new socially expected 
role for adulthood, fatherhood / motherhood… as 
well as reproducing new life beyond the historical 
bound age-limits. On the other hand, the apologetic 
and sympathetic attitudes of new, secularly individual 
rights centred, regulatory framework for ART, 
foster new parenthood even at advanced (60+) age 
cohorts. Furthermore, most developmental state’s 
further investment for biomedical sciences (as future 
championing technologies of life sciences) reinforces 
the complex, but contradictory, constellation of 
the individual’s life choice for new parenthood and 
baby-bearing; calling within a new challenging 
(constructive destructive forces?) biomedical 
technological advances. One such complex matrix 
is a challenge to social (historical bound) norms and 
ethics on the equal opportunities for men and women 
(for life creation), with the promotion of progressive 
rights for women to control their sovereign body for 
new human reproduction. 
4.2 Global Reproductive Tourism – Choice-driven 
New Flexible Human Reproduction Regime? 
Medical tourism in general and transnational 
ART in particular is booming globally. In spite of 
the difficulty to measure the scope for medical and 
“reproductive” trading, they are considered as a new 
major source for economic development. Accordingly, 
the worldwide market size for medical travel was 
close to US$60 billion (in 2008), and was expected 
to grow at double-digit rate, to US$100 billion by 
2020 (Whittaker 2010). Accordingly, it is estimated 
that there were approximately 5 million medical 
tourists worldwide; each spends an average of 
US$3,000 per surgery. Of that fi gure, some 550,000 
Americans travelled outside the US for medical care 
in 2011. This includes all medically-related costs and 
does not include patient travel or accommodations 
(Patientsbeyondborders 2012).
The top ten count r ies for medica l tour ism 
are: Brazil, Costa Rica, India, Korea, Malaysia, 
Mexico, Singapore, Taiwan, Thailand, Turkey; 
and the emerging ones are China, Puerto Rico, 
United Arab Emirates (UAE), United States 
(Patientsbeyondborders 2012). Among them, India 
and UAE stand out as the most pro-active ones for 
ART tourism, though their biomedical infrastructure 
and regulations for reproductive procedure differ 
much (Inhorn &  Shrivastav 2010; Palattiyil, et al. 
2010). 
Why people “exodus” for reproductive tourism? 
Empirical review on global reproductive tourism 
has identified seven major factors contributing to 
the phenonmenal “exit” making new life (Inhorn & 
Shrivastav 2010: 68S-69S): 
(i)- individual countries may prohibit a specific 
service for religious or ethical reasons;
(ii)- a specifi c service may be unavailable because of 
lack of expertise, personnel, and equipment;
(iii)- a service may be unavailable because it is not 
considered sufficiently safe or its risks are 
unknown; 
(iv)- certain categories of individuals may not receive 
a service, especially at public expense, on the 
basis of age, marital status, or sexual orientation; 
(v)- services may be unavailable because of shortages 
and waiting lists, especially for donor gametes; 
(vi)- some individuals may have privacy concerns; 
and 
(vii)- services may simply be cheaper in other 
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countries.
 Arguably, transnational surrogacy (egg, sperm and 
woman womb of global human reproduction trading 
chain in a globalizing world) is controversial not just 
in terms of the questionably intrusive technological 
procedure applying in, as well as taking advantages 
of, different regulatory state regimes on ART, 
ranging from complete ban on surrogacy to the 
almost free market like regime. USA, Great Britain, 
and Canada have policies governing surrogacy 
in the interests of both the surrogate mother and 
the commissioning couple, with clear guidelines 
related to payment for surrogacy. But in USA the 
legality of surrogacy differs from state to state. But 
countries like Australia, China, Denmark, France, 
Germany, Hong Kong Mexico, Spain, Switzerland, 
and Turkey have banned surrogacy -- contrasting 
Belgium, Finland, Guatemala, India, and other 
countries have few regulations regarding surrogacy. 
In different surrogacy markets, comparative costs to 
the commissioning parents range from about $80,000 
in the United States to $12,000 in India (Ross-Sheriff 
2012: 126).
The issues of (commercial) transnational surrogacy 
are three folds: (i) new globalizing market for 
new life (more than cross-borders adoption) with 
full spectrum of price-tagged ART services from 
egg+sperm to new born babies; (ii) enabling wealthy 
individuals to escape from a restricted reproductive 
regime; and (iii) pre-empting any likely questionably 
ethical and moral controversies. It could be said that 
transnational surrogacy champions reproductive 
technology par excellence for the affordable price 
(thanks to the wealth of the buyer of) new life. 
Juxtaposing the self-referentiality new biomedical 
science for human reproduction, those self selected 
wealthy, privileged people are escaping (or “exodus” 
en masse?) from socio-cultural -cum- ethical 
bondages of their society – isn’t it the new life praxis 
for new humanity in 21st Century and beyond? 
4.3 Reproductive Questions for New Life: 
Alternatives beyond Bio-Medicine?
Historically, and mostly likely be the case that, any 
regulatory body on new sciences operates within (and 
beyond) a fast-advancing, complex hence ethically 
challenging yet mostly uncharted spaces of sciences 
and humanity.
Transnational reproductive trading and surrogacy 
are core part of global-regional medical tourism in 
advanced global capitalism, with selective ART as 
a pay-tradable service for those who can afford but 
are not legally and/or ethically offered in their home 
country: with the ”all-in-one” reproductive-service- 
chain having the embodied services or biological 
offerings (egg+sperm and woman womb) of other 
people. But the challenge for global fl exible-trading 
regime of reproductive technology is obvious: people’s 
“exodus” for the liberalizing cost-efficient techno-
regulatory regimes has strong ethical ramification 
within and beyond bio-reproductive technology in 
global society, exacerbating the perils of humanity 
and systemic unsustainability (Palattiyil et al. 2010; 
Ross-Sheriff 2012; Whittaker 2010). 
Indeed, recent secular ethical frames to consider 
reproductive tourism are also sympathetic to, if not 
inclined to favor, the trading of money with bodies of 
egg, sperm and womb alike (Jaiswal 2012: 1-2): 
(a) the liberal feminist principle of women’s 
choice and freedom, which accepts contractual 
surrogacy as a service, as opposed to the 
socialist feminist principle of equity and 
fa i rness which regards it as potentia l ly 
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exploitat ive given the lack of economic 
opportunities to the surrogate, and 
(b) the extended equity principle, which questions 
India’s propriety in allowing “outsourcing” of 
pregnancy in a country with a dismal record of 
maternal mortality. 
Thanks to (or the curse of) ever-advancing bio-
sciences, the further expansion -cum- sophistication 
of various forms of (legal or illegally) “trading” for 
human (organ-) reproduction is inevitably in reality. 
But two critical domains for future development 
should be guided by ethical considerations: the 
hosting countries for reproductive tourism and 
the governance of f lexible trading of egg-sperm 
and the womb. First, policy development for those 
hosting countr ies (l ike India) of reproductive 
tourism should have equitably distribution of health 
resources between the reproductive sector (as a form 
of trading to earn foreign currencies?) and those 
non-reproductive (but critical) services. Second, 
as reproductive tourism is chaotically organized - 
the uncertainty and unprotected rights for all the 
concerned in transnational surrogacy, say the 
least; it is therefore indeed urgent for international 
governmental and non-governmental agencies to 
monitor and, possibly region-international regulate, 
the trading of egg-and-sperm and organs in ART 
mobility, like the regime against human traffi cking, 
that the rights of the surrogates and the concerned are 
safeguarded and exploitation minimized.
Furthermore, there are more normative questions 
to be raised: will biomedical endeavors towards 
alternative new life form(s) engender a paradigmatic 
shift from socio-cultural-historically fi xed humanity 
to  a  bound less  or  un l im ited one? Wi l l  new 
reproduction (with money can buy all) of human 
species bring more happiness and wellbeing for 
people at large?
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